White House Silent on Musk’s Drug Use During Trump Administration
The Trump White House and SpaceX remained silent regarding reports of Elon Musk’s extensive drug use during his time as a White House advisor. These reports, published in the New York Times, detail Musk’s alleged regular consumption of ketamine, Adderall, ecstasy, and psychedelic mushrooms. The White House’s refusal to comment on potential drug testing, coupled with SpaceX’s alleged advanced notice of Musk’s “random” drug tests, suggests a lack of oversight. The article highlights the severity of Musk’s alleged drug use, including its reported impact on his bladder health.
John Q. Hosedrinker